Medical Science Liaison - Western Canada

Indivior is a global pharmaceutical company that works tirelessly to change patients' lives by pioneering life-transforming treatments for substance use disorders and other serious mental illnesses. Founded as a division of Reckitt Benckiser in 1994 and becoming an independent entity in 2014, Indivior is dedicated to addressing the urgent public health crisis of opioid addiction through innovative medicines such as Sublocade and Suboxone.

With over 20 years of experience in opioid addiction treatment, Indivior employs a patient-focused approach with an overarching vision that all patients around the world should have access to evidence-based treatment for chronic conditions associated with addiction. Indivior has made significant strides in advocating for patients by emphasizing the importance of early intervention and comprehensive treatment strategies. Their commitment to improving mental health services positions them at the forefront of the pharmaceutical industry in tackling addiction and promoting sustainable recovery solutions.